Less Ads, More Data, More Tools Register for FREE

Pin to quick pickseEnergy Group Regulatory News (EAAS)

Share Price Information for eEnergy Group (EAAS)

Share Price is delayed by 15 minutes
Get Live Data
5.05    0.00 (0.00%)
Bid:
4.80
Ask:
5.30
Spread: 0.50 (10.417%)
Market Cap: £19.55m
EAAS Live PriceLast checked at - London Stock Exchange

Intraday eEnergy Group Share Chart

Improved Metalvalue Agreement

16 May 2013 07:00

RNS Number : 8338E
Alexander Mining PLC
16 May 2013
 

16 May 2013

Alexander Mining plc

('Alexander' or the 'Company')

Improved Metalvalue Agreement with Increased Royalties and Minimised Dilution

·; Alexander gross sales royalty entitlement doubled to reflect Alexander's know-how required specifically to develop each project

·; Minimised equity dilution

·; Good technical progress on key project in DRC

·; Encouraging testwork results for zinc recovery from electric arc furnace dust

Alexander is pleased to announce that further to almost one year's positive cooperation and excellent technical progress with Metalvalue Limited ('Metalvalue' - the technical consultant to Metalvalue Capital Holdings (MCH), the investment vehicle managed by Metalvalue Advisors SA) for the electric arc furnace dust ('EAFD') and Democratic Republic of the Congo ('DRC ') plant projects, a new Leaching Technology Licence Agreement (the 'New Agreement') between MCH and Alexander has been signed along the terms of the November 2012 agreement, which has been terminated. This is to reflect the closer understanding of the optimal way to advance projects in the future, and in particular the know-how input by Alexander at each step of the projects' development and necessary transmission to Metalvalue.

Martin Rosser, CEO, said that: "a major outcome is also a greatly improved gross sales royalty and, given Alexander's recently completed equity financing, the benefit of minimised equity dilution."

The focus of work with Metalvalue has been on two specific projects, namely the building of a commercial AmmLeach® copper/cobalt processing plant in the DRC ('DRC Project') and to investigate developing a plant for the recovery of zinc from EAFD. Also associated with these initiatives has been detailed technical work to establish a pilot plant in Australia in conjunction with Metalvalue.

Regarding the DRC Project, Metalvalue is investigating, with Alexander's technical involvement and in conjunction with major support from a leading commodity trading company, the use of a suitable existing plant in the DRC. This has entailed site visits and detailed analysis. Metalvalue hopes to progress detailed negotiations for a plant to produce initially copper cathode metal and also to secure a major supply of ore feed to the plant. The expected timetable to production is being prepared now.

Preliminary testwork by Alexander on recycling EAFD to produce a zinc product has shown highly encouraging results, and the next steps are being discussed with Metalvalue, including the possibility of a dedicated production plant

In the course of activity to date, both companies recognised that amendments to the November 2012 Agreement would be beneficial to reflect the technical services required to implement the use of Alexander's intellectual property and know-how specific to each project, its necessary transmission to Metalvalue and the practical requirements to progress these and other opportunities. Accordingly, it has been decided to negotiate a revised agreement. In the interim, the following has been agreed:

1. MCH has paid Alexander £200,000 in cash for Alexander shares at 3p per share, to be issued imminently.

2. MCH and Alexander will negotiate a revised Leaching Technology Licence Agreement ("Revised Agreement") on a best efforts basis and in good faith to establish more practical arrangements between MCH and Alexander that will be reflected in a new licensing agreement.

3. MCH has been granted an option, expiring 30 April 2014, to purchase 12m Alexander shares at 5p (a premium of 74% over Alexander's closing price of 2.88p) each (total proceeds if exercised of £600,000) as opposed to the previously announced 3p subscription price.

4. A New Agreement between MCH and Alexander has been signed along the terms of the November 2012 Agreement except for the following amendments that have been made:

4.1. The Alexander gross sales royalty entitlement for MCH to licence Alexander's Leaching Technology in the New Agreement has been increased from 1.0% to 2.0% of the Saleable Product value during the Royalty Period; and

4.2. the Second Tranche Payment of £800,000 condition has been reduced to the payment received of £200,000.

5. As per a term sheet separately signed between the two companies, MCH can make available a facility before the end of July 2013 for co-financing a pilot plant to be established in Australia through a £400,000 loan to Alexander ('Pilot Plant Loan'), provided Alexander has secured the necessary additional funding. If Alexander elects to proceed with the pilot plant and draws down the loan, receiving cleared funds from MCH, then agreed loan terms will apply.

In addition, if Alexander elects to draw down the loan, MCH would be granted exclusive rights for AXM's Leaching Technology at the agreed 2.0% gross sales royalty rate in the DRC and Zambia for copper, cobalt, nickel, zinc and molybdenum. However, Alexander would have a call option to buy back MCH's exclusivity rights for an agreed sum, valid until 1 January 2019.

6. If a new agreement has not been signed by 30 September 2013 then the New Agreement above will remain in force.

ENDS

 

For further information please contact:

 

Martin Rosser

Chief Executive

Mobile: +44 (0) 7770 865 341

 

Matt Sutcliffe

Executive Chairman

Mobile: +44 (0) 7887 930 758

Stephane Lamoine

Chief Executive Officer

Tel: +41 22 311 96 96

 

Alexander Mining plc

1st Floor

35 Piccadilly

London

W1J 0DW

Tel: +44 (0) 20 7292 1300

Fax: +44 (0) 20 7292 1313

Email: mail@alexandermining.com

Website: www.alexandermining.com

 

Metalvalue Advisors SA

8 Rue Eynard

Geneva 1205

Switzerland

 

 

 

Nominated Adviser and Broker

Northland Capital Partners Limited

Louis Castro / Lauren Kettle

+44 (0) 20 7796 8800

Public / Media Relations

Britton Financial PR

Tim Blackstone

+44 (0) 20 7242 9786

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGREAPSSFADDEFF
Date   Source Headline
1st Jun 20267:00 amRNSPublication of AR, Notice of AGM and Board Update
18th May 20267:00 amRNSDirectorate change
13th May 20267:00 amRNSBoard changes
30th Apr 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
16th Apr 20267:00 amRNSQ1 Trading Update, Revenue Recognition & Outlook
4th Mar 20267:00 amRNS-RContract wins
23rd Feb 20267:00 amRNSLoan Agreement
23rd Jan 20267:00 amRNSTrading Update
22nd Jan 20267:00 amRNSLaunch of new funding solution and first contract
19th Jan 20267:00 amRNSAppointment of Non-Executive Director
15th Dec 20257:00 amRNSFY Trading Update
27th Nov 20257:00 amRNSDirectorate change
17th Nov 20253:20 pmRNSAward of Options
12th Nov 20254:38 pmRNSSolar Agreement, Loan Agreement, Grant of Warrants
29th Oct 202511:39 amRNSHolding(s) in Company
27th Oct 20257:00 amRNS-RLargest EV Charging Project to Date with NHS
23rd Oct 20252:10 pmRNSHolding(s) in Company
20th Oct 20251:28 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSPreferred supplier for major solar contract
22nd Aug 20253:04 pmRNSHolding(s) in Company
21st Aug 20253:09 pmRNSHolding(s) in Company
19th Aug 202510:50 amRNSHolding(s) in Company
7th Aug 202512:13 pmRNSHolding(s) in Company
31st Jul 20255:17 pmRNSResult of AGM
22nd Jul 20257:00 amRNSUnaudited HY Results - Six Months Ended 30.06.25
3rd Jul 202510:46 amRNSNotice of AGM
30th Jun 20257:00 amRNSNotice of Results
13th Jun 20259:30 amRNSNotice of FY Results and Investor Presentation
3rd Jun 20259:25 amRNSHolding(s) in Company
20th May 202511:10 amRNSHolding(s) in Company
16th May 20257:00 amRNS£100m Partnership with Redaptive
7th Apr 20257:00 amRNS-RFramework win
26th Mar 20257:00 amRNS-RLaunch of SolarLife
24th Mar 20257:00 amRNS-RContracts wins and appointment to a Framework
11th Mar 20257:00 amRNS-RContract Wins
12th Feb 202511:17 amRNSHolding(s) in Company
3rd Feb 20257:00 amRNS-RInvestor Meet Company Presentation
30th Jan 20257:00 amRNSTrading update
19th Dec 20241:45 pmRNSAward of Options and PDMR Transactions
28th Nov 20247:00 amRNS-RLED Conversion Contract in Further Education
15th Oct 202410:45 amRNSHolding(s) in Company
1st Oct 20247:00 amRNSDirector appointment - additional information
30th Sep 20247:00 amRNSResults for the six months ended 30 June 2024
6th Sep 20247:00 amRNSHolding(s) in Company
8th Aug 20247:00 amRNSInvestor Presentations
26th Jul 20247:00 amRNSH1 24 Trading Update
28th Jun 20243:03 pmRNSResult of AGM
13th Jun 20247:00 amRNSNotice of General Meeting
30th Apr 20247:01 amRNSFinal Results for the 18 months ended 31 Dec 2023
22nd Apr 20247:00 amRNSMajor Contract Win with Spire Healthcare

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.